Log in to save to my catalogue

In vivo adenine base editing of PCSK9 in macaques reduces LDL cholesterol levels

In vivo adenine base editing of PCSK9 in macaques reduces LDL cholesterol levels

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8352781

In vivo adenine base editing of PCSK9 in macaques reduces LDL cholesterol levels

Publication information

Publisher

New York: Nature Publishing Group US

More information

Scope and Contents

Contents

Most known pathogenic point mutations in humans are C•G to T•A substitutions, which can be directly repaired by adenine base editors (ABEs). In this study, we investigated the efficacy and safety of ABEs in the livers of mice and cynomolgus macaques for the reduction of blood low-density lipoprotein (LDL) levels. Lipid nanoparticle–based delivery o...

Alternative Titles

Full title

In vivo adenine base editing of PCSK9 in macaques reduces LDL cholesterol levels

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8352781

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8352781

Other Identifiers

ISSN

1087-0156

E-ISSN

1546-1696

DOI

10.1038/s41587-021-00933-4

How to access this item